Washington University Team Wins $2M for River Blindness Biomarkers, Molecular Dx | GenomeWeb

NEW YORK (GenomeWeb News) – Researchers at Washington University School of Medicine have received a nearly $2 million grant from the Bill and Melinda Gates Foundation to identify biomarkers and develop a molecular diagnostic test for onchocerciasis, commonly called river blindness.

The disease, which is caused by the parasitic worm Onchocerca volvulus and causes visual impairment, skin lesions, and severe itching, affects around 37 million people, mostly in sub-Saharan Africa but also in Latin America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.